Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Voltarol (Systemic)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Voltarol 100mg suppositories
1001010C0BBADAC
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 483 |
|
Voltarol 50mg suppositories
1001010C0BBAJAU
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 269 |
|
Voltarol 75mg/3ml solution for injection ampoules
1001010C0BBACAA
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 103 |
|
Voltarol 25mg suppositories
1001010C0BBAIAT
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 37 |
|
Voltarol 12.5mg suppositories
1001010C0BBAEAB
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 9 |
|
Voltarol Retard 100mg tablets
1001010C0BBAFAF
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 1 |
|
Voltarol 25mg gastro-resistant tablets
1001010C0BBAAAD
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Voltarol 50mg dispersible tablets
1001010C0BBAGAJ
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Voltarol 50mg gastro-resistant tablets
1001010C0BBABAE
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Voltarol 75mg SR tablets
1001010C0BBAHAL
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.